Open access · CC-BY
via OpenAlex
Rejuvenation of mesenchymal stromal cells via partial reprogramming enables scalable generation of transcriptionally diverse MSC libraries
Haochen Tu, Aoi Hosaka, Genki Hichiwa, Yayan Wang, Kanako Kazuki, Toshiaki Tabata, Mitsuhiko Osaki, Yuji Nakayama, Iori Kanazawa, Kazuhisa Honma, Makoto T. Kimura, Xu Gao, Norichika Ogata, Satoshi Abe, Mitsuo Oshimura
Stem Cell Research & Therapy · 2026 · ▲ 1 citations
Abstract
BACKGROUND: Mesenchymal stromal cells (MSCs) are widely used in regenerative medicine, but their clinical utility is limited by replicative senescence(definition). Strategies that reverse aging while maintaining MSC identity are urgently needed. METHODS: We developed a non-integrating, temperature-sensitive Sendai virus (SeV)-mediated rejuvenation protocol transiently expressing hTERT, BMI1, and SV40T in human MSCs. Following SeV removal, we evaluated proliferation, telomere(definition) length, karyotype stability, transcriptomic reset, producing heterogeneity, and differentiation potential. RESULTS: Rejuvenated MSCs (rej-MSCs) demonstrated extended proliferation beyond 100 days, telomere elongation, and normal karyotypes after SeV clearance. Transcriptomic profiling showed a reset of senescence-associated programs while retaining mesenchymal identity. Functional analyses revealed clone-specific heterogeneity, including HGF-driven angiogenic activity. Multilineage differentiation capacity was preserved across rej-MSCs. CONCLUSIONS: This transient, non-integrating rejuvenation strategy establishes an operational definition of rej-MSCs and provides a transcriptionally diverse and scalable platform for MSC manufacturing and precision therapy design.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13287-026-04977-8
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Tu, H., Hosaka, A., Hichiwa, G., Wang, Y., Kazuki, K., Tabata, T., Osaki, M., Nakayama, Y., Kanazawa, I., Honma, K., Kimura, M.T., Gao, X., Ogata, N., Abe, S., Oshimura, M., & Kazuki, Y. (2026). Rejuvenation of mesenchymal stromal cells via partial reprogramming enables scalable generation of transcriptionally diverse MSC libraries. <em>Stem Cell Research & Therapy</em>. https://doi.org/10.1186/s13287-026-04977-8
Vancouver
Tu H, Hosaka A, Hichiwa G, Wang Y, Kazuki K, Tabata T, et al. Rejuvenation of mesenchymal stromal cells via partial reprogramming enables scalable generation of transcriptionally diverse MSC libraries. Stem Cell Research & Therapy. 2026. doi:10.1186/s13287-026-04977-8.
BibTeX
@article{haochen2026Rejuve,
title = {Rejuvenation of mesenchymal stromal cells via partial reprogramming enables scalable generation of transcriptionally diverse MSC libraries},
author = {Haochen Tu and Aoi Hosaka and Genki Hichiwa and Yayan Wang and Kanako Kazuki and Toshiaki Tabata and Mitsuhiko Osaki and Yuji Nakayama and Iori Kanazawa and Kazuhisa Honma and Makoto T. Kimura and Xu Gao and Norichika Ogata and Satoshi Abe and Mitsuo Oshimura and Yasuhiro Kazuki},
journal = {Stem Cell Research & Therapy},
year = {2026},
doi = {10.1186/s13287-026-04977-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurochemistry International 2017
Preprint · OA
Mitophagy in neurodegeneration and aging
Aging and Disease 2023
Open access · CC-BY
Mesenchymal Stem Cell Senescence during Aging:From Mechanisms to Rejuvenation Strategies
Springer eBooks 2025
Citation only
Aging and Neurodegeneration
Journal of the American College of Cardiology 2018
Open access · OA
Telomere Length as Cardiovascular Aging Biomarker
Stem Cell Research & Therapy 2025
Open access · CC-BY
Mesenchymal stem cell exosome therapy: current research status in the treatment of neurodegenerative diseases and the possibility of reversing normal brain aging
Turkish Journal of Clinical Research 2026
Open access · CC-BY